Pearl Bio
Build next-gen Biomaterials for Smart Biologics
- Business Model
- B2B
- Website
- pearlbio.com
- Last Round
- SeedAug 2023
- Rounds
- 1
About
Synthetic biology company using genome and ribosome engineering to produce novel biologics with diverse chemistries.
Summary
Pearl Bio is a Biotech company based in United States. Its most recent funding was a Seed round in Aug 2023. Investors include Khosla Ventures and US National Science Foundation.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2023
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pearl-bio"><img src="https://indexed.vc/api/badge/company/pearl-bio" alt="Pearl Bio on Indexed.vc" width="260" height="76" /></a>